A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

Histone deacetylases (HDACs) are enzymes involved in many important biological functions. They have been linked to a variety of cancers, psychiatric disorders, and other diseases. Since small molecules can serve as probes to study the relevant biological roles of HDACs, novel scaffolds are necessary to develop more efficient, selective drug candidates. Screening libraries of molecules may yield structurally diverse probes that bind these enzymes and modulate their functions in cells. Here we report a small molecule with a novel hydroxy-pyrimidine scaffold that inhibits multiple HDAC enzymes and modulates acetylation levels in cells. Analogs were synthesized in an effort to evaluate structure-activity relationships.

Knowledge Graph

Similar Paper

A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold
Bioorganic & Medicinal Chemistry Letters 2011.0
Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylases
Bioorganic & Medicinal Chemistry Letters 2010.0
N-Hydroxy-(4-oxime)-cinnamide: A versatile scaffold for the synthesis of novel histone deacetilase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and Biological Evaluation of N-Hydroxyphenylacrylamides and N-Hydroxypyridin-2-ylacrylamides as Novel Histone Deacetylase Inhibitors
Journal of Medicinal Chemistry 2010.0
2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors
Journal of Medicinal Chemistry 2007.0
Novel amide derivatives as inhibitors of histone deacetylase: Design, synthesis and SAR
European Journal of Medicinal Chemistry 2009.0
Histone Deacetylase Inhibitors
Journal of Medicinal Chemistry 2003.0
Synthesis and Biological Evaluation of 3-(4-Substituted-phenyl)-N-hydroxy-2-propenamides, a New Class of Histone Deacetylase Inhibitors
Journal of Medicinal Chemistry 2003.0
Discovery, Synthesis, and Pharmacological Evaluation of Spiropiperidine Hydroxamic Acid Based Derivatives as Structurally Novel Histone Deacetylase (HDAC) Inhibitors
Journal of Medicinal Chemistry 2011.0
Design, synthesis, and preliminary bioactivity studies of substituted purine hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors
MedChemComm 2014.0